The EMJ Podcast | Episode 159
This week, Jonathan is joined by Kevin Tracey, Feinstein Institutes for Medical Research, Manhasset, New York, USA, to explore bioelectronic medicine; its use in the treatment of inflammation, including rheumatoid arthritis; and its future. The pair further dives into the vagus nerve and the link between vagotomy and Parkinson’s disease, and the use of monoclonal anti-TNF antibodies to treat septic shock.
Spotify | Apple | Amazon Music | Download MP3 (40:20 mins)
Speaker bio:
Kevin Tracey’s career began at Boston College in Massachusetts, USA, where he achieved a BSc in chemistry. Tracey later went to Boston University, Massachusetts, USA, were he obtained his MD, which was followed by a residency in neurosurgery from Cornell University Medical College in New York City, USA. Throughout his career, Kevin has received numerous honours and awards, and has recently become a Fellow for the American Institute for Medical and Biological Engineering (AIMBE), and was awarded an honoris causa doctorate from the University of Fribourg in Switzerland. Tracey also co-founded a non-profit organisation called Global Sepsis Alliance, which supports the efforts of more than 1 million sepsis caregivers in over 70 countries. He is now President and CEO of the Feinstein Institutes for Medical Research, based in Manhasset, New York, in the USA, and Professor at the Institute of Bioelectric Medicine at the same organisation, as well as the Karches Family Distinguished Chair in Medical Research.
